spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levrero, M.
Right arrow Articles by Melino, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levrero, M.
Right arrow Articles by Melino, G.
Agami, R., Blandino, G., Oren, M. and Shaul, Y (1999). Interaction of c-Abl and p73 and their collaboration to induce apoptosis. Nature 399, 809-813.[Medline]

Amundson, S. A., Myers, T. G. and Fornace, A. J. Jr (1998). Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 17, 3287-3299.[Medline]

Balint, E., Bates, S. and Vousden, K. H (1999). Mdm2 binds p73 alpha without targeting degradation. Oncogene 18, 3923-3929.[Medline]

Baskaran, R., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M. B. and Wang, J. Y (1997). Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387, 516-519.[Medline]

Celli, J., Duijf, P., Hamel, B. C. J., Bamshad, M., Kramer, B., Smits, A. P. T., Newbury-Ecob, R., Hennekam, R. C. M., Van Buggenhout, G., Van Haeringen, A., Woods, C. G., Van Essen, A. J., De Waal, R., Vriend, G., Haber, D. A., Yang, A., McKeon, F., Brunner, H. G. and Van Bokhoven, H (1999). Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 99, 143-153.[Medline]

Chi, S.-W., Ayeda, A. and Arrowsmith, C. H (1999). Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain. EMBO J 18, 4438-4445.[Medline]

Cho, Y., Gorina, S., Jeffrey, P. D. and Pavletich, N. P (1994). Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355.[Abstract/Free Full Text]

Davison, T. S., Vagner, C., Kaghad, M., Ayed, A., Caput, D. and Arrowsmith, C. H (1999). p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53. J. Biol. Chem 274, 18709-18714.[Abstract/Free Full Text]

De Laurenzi, V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M. and Melino, G (1998). Two new p73 splice variants, gamma and delta, with different transcriptional activity. J. Exp. Med 188, 1763-1768.[Abstract/Free Full Text]

Di Como, C. J., Gaiddon, C. and Prives, C (1999). p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol. Cell. Biol 19, 1438-1449.[Abstract/Free Full Text]

Ding, Y., Inoue, T., Kamiyama, J., Tamura, Y., Ohtani-Fujita, N., Igata, E. and Sakai, T (1999). Molecular cloning and functional characterization of the upstream promoter region of the human p73 gene. DNA Res 6, 347-351.[Abstract]

Dobbelstein, M. and Roth, J (1998). The large T antigen of simian virus 40 binds and inactivates p53 but not p73. J. Gen. Virol 79, 3079-3083.[Abstract]

Dobner, T., Horikoshi, N., Rubenwolf, S. and Shenk, T (1996). Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272, 1470-1473.[Abstract]

Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A. Jr, Butel, J. S., Bradley. A (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221.[Medline]

Donehower, L. A., Godley, L. A., Aldaz, C. M., Pyle, R., Shi, Y. P., Pinkel, D., Gray, J., Bradley, A., Medina, D. and Varmus, H. E (1995). Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev 9, 882-895.[Abstract/Free Full Text]

el-Deiry, W. S (1998). Regulation of p53 downstream genes. Semin. Cancer Biol 8, 345-357.[Medline]

Ferreira, A. and Kosik, K. S (1996). Accelerated neuronal differentiation induced by p53 suppression. J. Cell Sci 109, 1509-1516.[Abstract]

Giaccia, A. J. and Kastan, M. B (1998). The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12, 2973-2983.[Free Full Text]

Gong, J. G., Costanzo, A., Yang, H. Q., Melino, G., Kaelin, W. G., Levrero, M. and Wang, J. Y. J (1999). The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 39, 806-809.

Gottlieb, T. M. and Oren, M (1998). p53 and apoptosis. Semin. Cancer Biol 8, 359-368.[Medline]

Han, S. Semba, S., Abe, T., Makino, N., Furukawa, T., Fukushige, S., Takahashi, H., Sakurada, A., Sato, M., Shiiba, K., Matsuno, S., Nimura, Y. and Nakagawara, A (1999). Infrequent somatic mutations of the p73 gene in various human cancers. Eur. J. Surg. Oncol 25, 194-198.[Medline]

Higashino, F., Pipas, J. M. and Shenk, T (1998). Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73. Proc. Nat. Acad. Sci. USA 95, 15683-15687.[Abstract/Free Full Text]

Hollstein, M., Sidransky, D. and Vogelstein, C. C (1991). p53 mutations in human cancers. Science 253, 49-53.[Abstract/Free Full Text]

Hollstein, M., Shomer, B., Greenblatt, M., Soussi, T., Hovig, E., Montesano, R. and Harris, C. C (1996). Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucl. Acids Res 24, 141-146.[Abstract/Free Full Text]

Ichimiya, S., Nimura, Y., Kageyama, H., Takada, N., Sunahara, M., Shishikura, T., Nakamura, Y., Sakiyama, S., Seki, N., Ohira, M., Kaneko, Y., McKeon, F., Caput, D,. and Nakagawara, A (1999). p73 at chromosome 1p36. 3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene 18, 1061-1066.[Medline]

Jost, C. A., Marin, M. C. and Kaelin, W. G. Jr (1997). p73 is a human p53 related protein that can induce apoptosis. Nature 389, 191-194.[Medline]

Kaghad, M., Bonnet, H., Yang, A., Creacier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lellas, J. M., Dumont, X., Ferrara, P., McKeon, F. and Caput, D (1997). Monoallelically expressed gene related to p53 at 1p36, a region frequentely deleted in neuroblastoma and other human cancers. Cell 90, 809-819.[Medline]

Ko, L. J. and Prives, C (1996). p53: puzzle and paradigm. Genes Dev 10, 1054-1072.[Free Full Text]

Kovalev, S., Marchenko, N., Swendeman, S., LaQuaglia, M., Moll, U. M (1998). Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ 9, 897-903.[Abstract]

Kroiss, M. M., Bosserhoff, A. K., Vogt, T., Buettner, R., Bogenrieder, T., Landthaler, M. and Stolz, W (1998). Loss of expression or mutations in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanomas. Melanoma Res 8, 504-509.[Medline]

Lane, D. P (1992). Cancer. p53, guardian of the genome. Nature 358, 15-16.[Medline]

Lee, C. W. and La Thangue, N. B (1999). Promoter specificity and stability control of the p53-related protein p73. Oncogene 18, 4171-4181.[Medline]

Levine, A. J (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.[Medline]

Liu, Z. G., Baskaran, R., Lea-Chou, E. T., Wood, L. D., Chen, Y., Karin, M. and Wang, J. Y (1996). Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 384, 273-276.[Medline]

Mai, M., Qian, C., Yokomizo, A., Tindall, D. J., Bostwick, D., Polychronakos, C., Smith, D. I. and Liu, W (1998). Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene 17, 1739-1741.[Medline]

Marin, M. C., Jost, C. A., Irwin, M. S., DeCaprio, J. A., Caput, D. and Kaelin, W. G. Jr (1998). Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol. Cell. Biol 18, 6316-6324.[Abstract/Free Full Text]

Mihara, M., Nimura, Y., Ichimiya, S., Sakiyama, S., Kajikawa, S., Adachi W., Amano, J. and Nakagawara A (1999). Absence of mutation of the p73 gene localized at chromosome 1p36. 3 in hepatocellular carcinoma. Br. J. Cancer 79, 164-167.[Medline]

Mills, A. A., Zheng, B., Wang, X. J., Vogel, H., Roop, D. R. and Bradley, A (1999). p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398, 708-713.[Medline]

Nimura, Y., Mihara, M., Ichimiya, S., Sakiyama, S., Seki, N., Ohira, M., Nomura, N., Fujimori, M., Adachi, W., Amano, J., He, M., Ping, Y. M. and Nakagawara, A (1998). p73, a gene related to p53, is not mutated in esophageal carcinomas. Int. J. Cancer 7, 437-440.

Nomoto, S., Haruki, N., Kondo, M., Konishi, H., Takahashi, T., Takahashi, T. and Takahashi, T (1998). Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36. 33 in human lung cancers. Cancer Res 58, 1380-1383.[Abstract/Free Full Text]

Ongkeko, W. M., Wang, X. Q., Siu, W. Y., Lau, A. W., Yamashita, K., Harris, A. L., Cox, L. S. and Poon, R. Y (1999). MDM2 and MDMX bind and stabilize the p53-related protein p73. Curr. Biol 15, 829-833.

Oren, M (1999). Regulation of the p53 tumor suppressor protein. J. Biol. Chem 274, 36031-36034.[Free Full Text]

Prabhu, N. S., Somasundaram, K., Satyamoorthy, K., Herlyn, M. and el-Deiry, W. S (1998). p73beta, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells. Int. J. Oncol 13, 5-9.

Prives, C. and Hall, P. A (1999). The p53 pathway. J. Pathol 187, 112-126.[Medline]

Roth, J., Konig, C., Wienzek, S., Weigel, S., Ristea, S. and Dobbelstein, M (1998). Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins. J. Virol 72, 8510-8516.[Abstract/Free Full Text]

Shishikura, T., Ichimiya, S., Ozaki, T., Nimura, Y., Kageyama, H., Nakamura, Y., Sakiyama, S., Miyauchi, M., Yamamoto, N., Suzuki, M., Nakajima, N. and Nakagawara A (1999). Mutational analysis of the p73 gene in human breast cancers. Int. J. Cancer 84, 321-325.[Medline]

Steegenga, W. T., Shvarts, A., Riteco, N., Bos, J. L. and Jochemsen, A. G (1999). Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins. Mol. Cell Biol 9, 3885-3894.

Sunahara, M., Ichimiya, S., Nimura, Y., Takada, N., Sakiyama, S., Sato, Y., Todo, S., Adachi, W., Amano, J. and Nakagawara, A (1998). Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. Int. J. Oncol 13, 319-323.

Takada, N., Ozaki, T., Ichimiya, S., Todo, S. and Nakagawara, A (1999). Identification of a transactivation activity in the COOH-terminal region ofp73 which is impaired in the naturally occurring mutants found in human neuroblastomas. Cancer Res 59, 2810-2814.[Abstract/Free Full Text]

Takahashi, H., Ichimiya, S., Nimura, Y., Watanabe, M., furusato, M., Wakui, S., Yatani, R., Aizawa, S. and Nakagawara, A (1998). Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res 58, 2076-2077.[Abstract/Free Full Text]

Tannapfel, A., Wasner, M., Krause, K., Geissler, F., Katalinic, A., Hauss, G., Mossner, J., Engeland, K. and Wittekind, C (1999). Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J. Nat. Cancer Inst 91, 1154-1158.[Abstract/Free Full Text]

Tannapfel, A., Engeland, K., Weinans, L., Katalinic, A., Hauss, J., Mossner, J. and Wittekind C (1999). Expression of p73, a novel protein related to the p53 tumour suppressor p53 and apoptosis in cholangiocellular carcinoma of the liver. Br. J. Cancer 80, 1069-1074.[Medline]

Tao, W. and Levine, A. J (1999). P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc. Nat. Acad. Sci. USA 96, 6937-6941.[Abstract/Free Full Text]

Tsao, H., Zhang, X., Majewski, P. and Haluska, F (1999). Mutational and expression analysis of the p73 gene in melanoma cell lines. Cancer Res 59, 172-174.[Abstract/Free Full Text]

Ueda, Y., Hijikata, M., Takagi, S., Chiba, T. and Shimotohno, K (1999). New p73 variants with altered C-terminal structures have varied transcriptional activities. Oncogene 18, 4993-4998.[Medline]

Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dotsch, V., Andrews, N. C., Caput, D. and McKeon, F (1998). p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2, 305-316.

Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Doetsch, V., Andrews, N. C., Caput, D. and McKeon, F (1999). p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398, 714-718.[Medline]

Yang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A., McKeon, F. and Caput, D (2000). p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404, 99-103.[Medline]

Yokomizo, A., Mai, M., Tindall, D. J., Cheng, L., Bostwick, D. G., Naito, S., Smith, D. I. and Liu, W (1999). Overexpression of the wild type p73 gene in human bladder cancer. Oncogene 18, 1629-1633.[Medline]

Yokozaki, H., Shitara, Y., Fujimoto, J., Hiyama, T., Yasui, W. and Tahara, E (1999). Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype. Int. J. Cancer 83, 192-196.[Medline]

Yu, J., Zhang. L., Hwang, P. M., Rago, C., Kinlzer, K. W. and Vogelstein, B (1999). Identification and classification of p53-regulated genes. Proc. Nat. Acad. Sci. USA 96, 14517-14522.[Abstract/Free Full Text]

Yuan, Z. M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y. Y., Lu, H., Kharbanda, S., Weichselbaum, R. and Kufe, D (1999). p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 399, 814-817.[Medline]

Zaika, A. I., Kovalev, S., Marchenko, N. D. and Moll, U. M (1999). Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res 59, 3257-3263.[Abstract/Free Full Text]

Zeng, X., Chen, L., Jost, C. A., Maya, R., Keller, D., Wang, X., Kaelin, W. G. Jr, Oren, M., Chen, J. and Lu, H (1999). MDM2 suppresses p73 function without promoting p73 degradation. Mol. Cell Biol 5, 3257-3266.

Zeng, X., Li, X., Miller, A., Yuan, Z., Yuan, W., Kwok, R. P., Goodman, R. and Lu, H (2000). The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis. Mol. Cell Biol 20, 1299-1310.[Abstract/Free Full Text]

Zhang, Y. and Xiong, Y (1999). Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell 5, 579-591.

Zhu, J., Jiang, J., Zhou, W. and Chen, X (1988). The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res 58, 5061-5065.[Abstract/Free Full Text]


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
I. Marinovic-Terzic, A. Yoshioka-Yamashita, H. Shimodaira, E. Avdievich, I. C. Hunton, R. D. Kolodner, W. Edelmann, and J. Y. J. Wang
Apoptotic function of human PMS2 compromised by the nonsynonymous single-nucleotide polymorphic variant R20Q
PNAS, September 16, 2008; 105(37): 13993 - 13998.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. Tozluoglu, E. Karaca, T. Haliloglu, and R. Nussinov
Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis
Nucleic Acids Res., September 1, 2008; 36(15): 5033 - 5049.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. Muscolini, R. Cianfrocca, A. Sajeva, S. Mozzetti, G. Ferrandina, A. Costanzo, and L. Tuosto
Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells
Mol. Cancer Ther., June 1, 2008; 7(6): 1410 - 1419.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
S. S. El-Dahr, K. Aboudehen, and Z. Saifudeen
Transcriptional control of terminal nephron differentiation
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1273 - F1278.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. E. Kravchenko, G. V. Ilyinskaya, P. G. Komarov, L. S. Agapova, D. V. Kochetkov, E. Strom, E. I. Frolova, I. Kovriga, A. V. Gudkov, E. Feinstein, et al.
Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway
PNAS, April 29, 2008; 105(17): 6302 - 6307.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
G. Livera, B. Petre-Lazar, M.-J. Guerquin, E. Trautmann, H. Coffigny, and R. Habert
p63 null mutation protects mouse oocytes from radio-induced apoptosis
Reproduction, January 1, 2008; 135(1): 3 - 12.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. Lokshin, Y. Li, C. Gaiddon, and C. Prives
p53 and p73 display common and distinct requirements for sequence specific binding to DNA
Nucleic Acids Res., January 12, 2007; 35(1): 340 - 352.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Maruyama, F. Aoki, M. Toyota, Y. Sasaki, H. Akashi, H. Mita, H. Suzuki, K. Akino, M. Ohe-Toyota, Y. Maruyama, et al.
Comparative Genome Analysis Identifies the Vitamin D Receptor Gene as a Direct Target of p53-Mediated Transcriptional Activation.
Cancer Res., May 1, 2006; 66(9): 4574 - 4583.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
J. Laurikkala, M. L. Mikkola, M. James, M. Tummers, A. A. Mills, and I. Thesleff
p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation
Development, April 15, 2006; 133(8): 1553 - 1563.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Wang, A. J. Garcia, M. Wu, D. A. Lawson, O. N. Witte, and H. Wu
Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation
PNAS, January 31, 2006; 103(5): 1480 - 1485.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Jain, S. Gupta, Ch. Sudhakar, V. Radha, and G. Swarup
Role of p73 in Regulating Human Caspase-1 Gene Transcription Induced by Interferon-{gamma} and Cisplatin
J. Biol. Chem., November 4, 2005; 280(44): 36664 - 36673.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Merlo, M. Fulco, A. Costanzo, R. Mangiacasale, S. Strano, G. Blandino, Y. Taya, P. Lavia, and M. Levrero
A Role of p73 in Mitotic Exit
J. Biol. Chem., August 26, 2005; 280(34): 30354 - 30360.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. MacPartlin, S. Zeng, H. Lee, D. Stauffer, Y. Jin, M. Thayer, and H. Lu
p300 Regulates p63 Transcriptional Activity
J. Biol. Chem., August 26, 2005; 280(34): 30604 - 30610.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Saifudeen, V. Diavolitsis, J. Stefkova, S. Dipp, H. Fan, and S. S. El-Dahr
Spatiotemporal Switch from {Delta}Np73 to TAp73 Isoforms during Nephrogenesis: IMPACT ON DIFFERENTIATION GENE EXPRESSION
J. Biol. Chem., June 17, 2005; 280(24): 23094 - 23102.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S.-J. Zheng, S.-E. Lamhamedi-Cherradi, P. Wang, L. Xu, and Y. H. Chen
Tumor Suppressor p53 Inhibits Autoimmune Inflammation and Macrophage Function
Diabetes, May 1, 2005; 54(5): 1423 - 1428.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. A. Johnson, E. M. Shepard, and K. W. Scotto
Differential Regulation of MDR1 Transcription by the p53 Family Members: ROLE OF THE DNA BINDING DOMAIN
J. Biol. Chem., April 8, 2005; 280(14): 13213 - 13219.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Gonzalez, M. M. Perez-Perez, E. Hernando, M. Serrano, and C. Cordon-Cardo
p73{beta}-Mediated Apoptosis Requires p57kip2 Induction and IEX-1 Inhibition
Cancer Res., March 15, 2005; 65(6): 2186 - 2192.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C.-Y. Li, J. Zhu, and J. Y. J. Wang
Ectopic Expression of p73{alpha}, but Not p73{beta}, Suppresses Myogenic Differentiation
J. Biol. Chem., January 21, 2005; 280(3): 2159 - 2164.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
E. Munarriz, D. Barcaroli, A. Stephanou, P. A. Townsend, C. Maisse, A. Terrinoni, M. H. Neale, S. J. Martin, D. S. Latchman, R. A. Knight, et al.
PIAS-1 Is a Checkpoint Regulator Which Affects Exit from G1 and G2 by Sumoylation of p73
Mol. Cell. Biol., December 15, 2004; 24(24): 10593 - 10610.
[Abstract] [Full Text] [PDF]

Home page
 NeuroscientistHome page
W. B. Jacobs, G. S. Walsh, and F. D. Miller
Neuronal Survival and p73/p63/p53: A Family Affair
Neuroscientist, October 1, 2004; 10(5): 443 - 455.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
Y. Daniely, G. Liao, D. Dixon, R. I. Linnoila, A. Lori, S. H. Randell, M. Oren, and A. M. Jetten
Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium
Am J Physiol Cell Physiol, July 1, 2004; 287(1): C171 - C181.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Howell, C. Borchers, and S. L. Milgram
Heterogeneous Nuclear Ribonuclear Protein U Associates with YAP and Regulates Its Co-activation of Bax Transcription
J. Biol. Chem., June 18, 2004; 279(25): 26300 - 26306.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
T. Kikuchi, S. Ichimiya, T. Kojima, L. Crisa, S. Koshiba, A. Tonooka, N. Kondo, P. T. van der Saag, S. Yokoyama, and N. Sato
Expression profiles and functional implications of p53-like transcription factors in thymic epithelial cell subtypes
Int. Immunol., June 1, 2004; 16(6): 831 - 841.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
B. N. Chau, T.-T. Chen, Y. Y. Wan, J. DeGregori, and J. Y. J. Wang
Tumor Necrosis Factor Alpha-Induced Apoptosis Requires p73 and c-ABL Activation Downstream of RB Degradation
Mol. Cell. Biol., May 15, 2004; 24(10): 4438 - 4447.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
N. Billon, A. Terrinoni, C. Jolicoeur, A. McCarthy, W. D. Richardson, G. Melino, and M. Raff
Roles for p53 and p73 during oligodendrocyte development
Development, March 15, 2004; 131(6): 1211 - 1220.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Fulco, A. Costanzo, P. Merlo, R. Mangiacasale, S. Strano, G. Blandino, C. Balsano, P. Lavia, and M. Levrero
p73 Is Regulated by Phosphorylation at the G2/M Transition
J. Biol. Chem., December 5, 2003; 278(49): 49196 - 49202.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
I Dianzani, E Garelli, P Gustavsson, A Carando, B Gustafsson, N Dahl, and G Anneren
Rapp-Hodgkin and AEC syndromes due to a new frameshift mutation in the TP63 gene
J. Med. Genet., December 1, 2003; 40(12): e133 - 133.
[Full Text]

Home page
 Mol. Cell. Biol.Home page
S. Gonzalez, C. Prives, and C. Cordon-Cardo
p73{alpha} Regulation by Chk1 in Response to DNA Damage
Mol. Cell. Biol., November 15, 2003; 23(22): 8161 - 8171.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Frasca, V. Vella, A. Aloisi, A. Mandarino, E. Mazzon, R. Vigneri, and P. Vigneri
p73 Tumor-Suppressor Activity Is Impaired in Human Thyroid Cancer
Cancer Res., September 15, 2003; 63(18): 5829 - 5837.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
G. Grillo, F. Licciulli, S. Liuni, E. Sbisa, and G. Pesole
PatSearch: a program for the detection of patterns and structural motifs in nucleotide sequences
Nucleic Acids Res., July 1, 2003; 31(13): 3608 - 3612.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
S. Ruiz, C. Segrelles, A. Bravo, M. Santos, P. Perez, H. Leis, J. L. Jorcano, and J. M. Paramio
Abnormal epidermal differentiation and impaired epithelial-mesenchymal tissue interactions in mice lacking the retinoblastoma relatives p107 and p130
Development, June 1, 2003; 130(11): 2341 - 2353.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. J. Freebern, J. L. Smith, S. S. Chaudhry, C. M. Haggerty, and K. Gardner
Novel Cell-specific and Dominant Negative Anti-apoptotic Roles of p73 in Transformed Leukemia Cells
J. Biol. Chem., January 17, 2003; 278(4): 2249 - 2255.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
P. Ghioni, F. Bolognese, P. H. G. Duijf, H. van Bokhoven, R. Mantovani, and L. Guerrini
Complex Transcriptional Effects of p63 Isoforms: Identification of Novel Activation and Repression Domains{dagger}
Mol. Cell. Biol., December 15, 2002; 22(24): 8659 - 8668.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Hackzell, H. Uramoto, H. Izumi, K. Kohno, and K. Funa
p73 Independent of c-Myc Represses Transcription of Platelet-derived Growth Factor beta -Receptor through Interaction with NF-Y
J. Biol. Chem., October 11, 2002; 277(42): 39769 - 39776.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Belachew, A. A. Aguirre, H. Wang, F. Vautier, X. Yuan, S. Anderson, M. Kirby, and V. Gallo
Cyclin-Dependent Kinase-2 Controls Oligodendrocyte Progenitor Cell Cycle Progression and Is Downregulated in Adult Oligodendrocyte Progenitors
J. Neurosci., October 1, 2002; 22(19): 8553 - 8562.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. A. Ince, A. P. Cviko, B. J. Quade, A. Yang, F. D. McKeon, G. L. Mutter, and C. P. Crum
p63 Coordinates Anogenital Modeling and Epithelial Cell Differentiation in the Developing Female Urogenital Tract
Am. J. Pathol., October 1, 2002; 161(4): 1111 - 1117.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Uramoto, H. Izumi, T. Ise, M. Tada, T. Uchiumi, M. Kuwano, K. Yasumoto, K. Funa, and K. Kohno
p73 Interacts with c-Myc to Regulate Y-box-binding Protein-1 Expression
J. Biol. Chem., August 23, 2002; 277(35): 31694 - 31702.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E.-J. Kim, J.-S. Park, and S.-J. Um
Identification and Characterization of HIPK2 Interacting with p73 and Modulating Functions of the p53 Family in Vivo
J. Biol. Chem., August 23, 2002; 277(35): 32020 - 32028.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Allart, H. Martin, C. Detraves, J. Terrasson, D. Caput, and C. Davrinche
Human Cytomegalovirus Induces Drug Resistance and Alteration of Programmed Cell Death by Accumulation of Delta N-p73alpha
J. Biol. Chem., August 2, 2002; 277(32): 29063 - 29068.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Morena, S. Riccioni, A. Marchetti, A. T. Polcini, A. M. Mercurio, G. Blandino, A. Sacchi, and R. Falcioni
Expression of the beta 4 integrin subunit induces monocytic differentiation of 32D/v-Abl cells
Blood, June 17, 2002; 100(1): 96 - 106.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Strano, G. Fontemaggi, A. Costanzo, M. G. Rizzo, O. Monti, A. Baccarini, G. Del Sal, M. Levrero, A. Sacchi, M. Oren, et al.
Physical Interaction with Human Tumor-derived p53 Mutants Inhibits p63 Activities
J. Biol. Chem., May 17, 2002; 277(21): 18817 - 18826.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Yan, H. Wang, and D. D. Boyd
ATF3 Represses 72-kDa Type IV Collagenase (MMP-2) Expression by Antagonizing p53-dependent trans-Activation of the Collagenase Promoter
J. Biol. Chem., March 22, 2002; 277(13): 10804 - 10812.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Sasaki, S. Ishida, I. Morimoto, T. Yamashita, T. Kojima, C. Kihara, T. Tanaka, K. Imai, Y. Nakamura, and T. Tokino
The p53 Family Member Genes Are Involved in the Notch Signal Pathway
J. Biol. Chem., January 4, 2002; 277(1): 719 - 724.
[Abstract] [Full Text]

Home page
 Mol. Cell. Biol.Home page
G. Fontemaggi, A. Gurtner, S. Strano, Y. Higashi, A. Sacchi, G. Piaggio, and G. Blandino
The Transcriptional Repressor ZEB Regulates p73 Expression at the Crossroad between Proliferation and Differentiation
Mol. Cell. Biol., December 15, 2001; 21(24): 8461 - 8470.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
P. C. Hollenhorst, G. Pietz, and C. A. Fox
Mechanisms controlling differential promoter-occupancy by the yeast forkhead proteins Fkh1p and Fkh2p: implications for regulating the cell cycle and differentiation
Genes & Dev., September 15, 2001; 15(18): 2445 - 2456.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. K. El-Naggar, S. Lai, G. L. Clayman, B. Mims, S. M. Lippman, M. Coombes, M. A. Luna, and G. Lozano
p73 gene alterations and expression in primary oral and laryngeal squamous carcinomas
Carcinogenesis, May 1, 2001; 22(5): 729 - 735.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
C. Gaiddon, M. Lokshin, J. Ahn, T. Zhang, and C. Prives
A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core Domain
Mol. Cell. Biol., March 1, 2001; 21(5): 1874 - 1887.
[Abstract] [Full Text]

Home page
 Cell Growth Differ.Home page
S. V. Gaitonde, W. Qi, R. R. Falsey, N. Sidell, and J. D. Martinez
Morphologic Conversion of a Neuroblastoma-derived Cell Line by E6-mediated p53 Degradation
Cell Growth Differ., January 1, 2001; 12(1): 19 - 27.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
S. Strano, E. Munarriz, M. Rossi, L. Castagnoli, Y. Shaul, A. Sacchi, M. Oren, M. Sudol, G. Cesareni, and G. Blandino
Physical Interaction with Yes-associated Protein Enhances p73 Transcriptional Activity
J. Biol. Chem., April 27, 2001; 276(18): 15164 - 15173.
[Abstract] [Full Text] [PDF]